Boosting the clearance of hepatic Z-AAT aggregates by autophagy inducers or gene overexpression can efficiently alleviate liver damages in pre-clinical animal models of AATD [192,193,194,195]. This evidence concerns the gene SERPINA1 and alpha 1-antitrypsin deficiency.